Philips to Buy Medical Device Maker Spectranetics for 1.9 Billion Euros | Healthcare Informatics Magazine | Health IT | Information Technology Skip to content Skip to navigation

Philips to Buy Medical Device Maker Spectranetics for 1.9 Billion Euros

June 29, 2017
by Heather Landi
| Reprints

Amsterdam, the Netherlands-based health technology company Royal Philips announced it is acquiring Spectranetics Corporation, a Colorado Springs, Colorado-based medical device maker, for 1.9 billion Euros.

Spectranetics’ device portfolio includes vascular intervention devices to treat coronary and peripheral artery disease and lead management for the minimally invasive removal of implanted pacemaker and implantable cardioverter defibrillator (ICD) leads.

Philips will offer $38.50 per share in cash for the medical device company, which represents a 27 percent premium to the company’s closing price on Tuesday, according to a Philips press release.

The implied enterprise value is approximately EUR 1.9 billion, inclusive of Spectranetics’ cash and debt, or about $2.16 billion in U.S. dollars.

The acquisition will help to accelerate Philips expansion in image-guided therapy devices to treat cardiac and peripheral vascular disease, the company said, and would strengthen Philips’ position in a 6-bilion-Euro market.

 According to a Philips press release, Spectranetics is growing double digits and its device portfolio includes a range of laser atherectomy catheters for treatment of blockages with laser energy in both coronary and peripheral arteries and the AngioSculpt scoring balloon used to mechanically push a blockage aside in both peripheral and coronary arteries.

“Today’s exciting announcement follows a series of bolt-on acquisitions to strengthen our portfolio across the health continuum,” Frans van Houten, CEO of Royal Philips, said in a statement. “Building on the successful integration of the Volcano acquisition in early 2015, we are now accelerating our strategic expansion into therapy devices with the agreement to acquire Spectranetics.”

Scott Drake, president and CEO of Spectranetics, said in a prepared statement, “Combining Philips’ innovations in image-guided therapy with Spectranetics’ portfolio and expertise in the therapeutic device space will create exciting opportunities and allow us to accelerate growth. As part of Philips, we will have the scale and resources to expand Spectranetics’ portfolio of highly differentiated products, our robust innovation pipeline, and our clinical data compendium

Get the latest information on Health IT and attend other valuable sessions at this two-day Summit providing healthcare leaders with educational content, insightful debate and dialogue on the future of healthcare and technology.

Learn More

Topics

News

Adam Boehler Tapped by Azar to Serve as Senior Value-Based Care Advisor

Adam Boehler, currently director of CMMI, has also been named the senior advisor for value-based transformation and innovation, HHS Secretary Alex Azar announced.

Vivli Launches Clinical Research Data-Sharing Platform

On July 19 a new global data-sharing and analytics platform called Vivli was unveiled. The nonprofit group’s mission is to promote, coordinate and facilitate scientific sharing and reuse of clinical research data.

Survey: More Effective IT Needed to Improve Patient Safety

In a Health Catalyst survey, physicians, nurses and healthcare executives said ineffective information technology, and the lack of real-time warnings for possible harm events, are key obstacles to achieving their organizations' patient safety goals.

Physicians Still Reluctant to Embrace Virtual Tech, Survey Finds

While consumers and physicians agree that virtual healthcare holds great promise for transforming care delivery, physicians still remain reluctant to embrace the technologies, according to a new Deloitte Center for Health Solutions survey.

Geisinger, AstraZeneca Partner on Asthma App Suite

Geisinger has partnered with pharmaceutical company AstraZeneca to create a suite of products that integrate into the electronic health record and engage asthma patients and their providers in co-managing the disease.

Analysis: Healthcare Ransomware Attacks Decline in First Half of 2018

In the first half of 2018, ransomware events in major healthcare data breaches diminished substantially compared to the same time period last year, as cyber attackers move on to more profitable activities, such as cryptojacking, according to a new report form cybersecurity firm Cryptonite.